120 related articles for article (PubMed ID: 1645624)
1. Electrophysiological effects of left ventricular hypertrophy. Effect of calcium and potassium channel blockade.
Kowey PR; Friechling TD; Sewter J; Wu Y; Sokil A; Paul J; Nocella J
Circulation; 1991 Jun; 83(6):2067-75. PubMed ID: 1645624
[TBL] [Abstract][Full Text] [Related]
2. Modulation of ventricular fibrillation in the isolated heart: the role of slow calcium channel activity under continuous perfusion.
Amitzur G; Pogatz V; Novikov I; Kaplinsky E; Eldar M
J Cardiovasc Pharmacol; 2000 Jan; 35(1):16-28. PubMed ID: 10630729
[TBL] [Abstract][Full Text] [Related]
3. Effect of left ventricular hypertrophy and its regression on ventricular electrophysiology and vulnerability to inducible arrhythmia in the feline heart.
Rials SJ; Wu Y; Ford N; Pauletto FJ; Abramson SV; Rubin AM; Marinchak RA; Kowey PR
Circulation; 1995 Jan; 91(2):426-30. PubMed ID: 7805247
[TBL] [Abstract][Full Text] [Related]
4. Effect of gallopamil on electrophysiologic abnormalities and ventricular arrhythmias associated with left ventricular hypertrophy in the feline heart.
Kowey PR; O'Brien R; Wu Y; Sewter J; Sokil A; Nocella J; Rials SJ
Am Heart J; 1992 Oct; 124(4):898-905. PubMed ID: 1388327
[TBL] [Abstract][Full Text] [Related]
5. Ventricular tachyarrhythmias in rats with acute myocardial infarction involves activation of small-conductance Ca2+-activated K+ channels.
Gui L; Bao Z; Jia Y; Qin X; Cheng ZJ; Zhu J; Chen QH
Am J Physiol Heart Circ Physiol; 2013 Jan; 304(1):H118-30. PubMed ID: 23086994
[TBL] [Abstract][Full Text] [Related]
6. The effect of bretylium and clofilium on dispersion of refractoriness and vulnerability to ventricular fibrillation in the ischemic feline heart.
Kowey PR; Friehling TD; O'Connor KM; Wetstein L; Kelliher GJ
Am Heart J; 1985 Aug; 110(2):363-70. PubMed ID: 4025111
[TBL] [Abstract][Full Text] [Related]
7. The effect of beta-adrenergic blockade on vulnerability to ventricular fibrillation and inducibility of ventricular arrhythmia in short- and long-term feline infarction models.
Luketich J; Friehling TD; O'Connor KM; Kowey PR
Am Heart J; 1989 Aug; 118(2):265-71. PubMed ID: 2750648
[TBL] [Abstract][Full Text] [Related]
8. Dynamic mechanism for initiation of ventricular fibrillation in vivo.
Gelzer AR; Koller ML; Otani NF; Fox JJ; Enyeart MW; Hooker GJ; Riccio ML; Bartoli CR; Gilmour RF
Circulation; 2008 Sep; 118(11):1123-9. PubMed ID: 18725487
[TBL] [Abstract][Full Text] [Related]
9. Regression of left ventricular hypertrophy with captopril restores normal ventricular action potential duration, dispersion of refractoriness, and vulnerability to inducible ventricular fibrillation.
Rials SJ; Wu Y; Xu X; Filart RA; Marinchak RA; Kowey PR
Circulation; 1997 Aug; 96(4):1330-6. PubMed ID: 9286966
[TBL] [Abstract][Full Text] [Related]
10. Acute electrophysiologic effects and antiarrhythmic/antifibrillatory activity of intravenous amiodarone in a chronic feline infarction model.
Marinchak RA; O'Connor KM; Friehling TD; Kowey PR
J Cardiovasc Pharmacol; 1989 Sep; 14(3):389-95. PubMed ID: 2476617
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiologic effects of left ventricular hypertrophy in the intact cat.
Shechter JA; O'Connor KM; Friehling TD; Mark R; Uboh C; Kowey PR
Am J Hypertens; 1989 Feb; 2(2 Pt 1):81-5. PubMed ID: 2521793
[TBL] [Abstract][Full Text] [Related]
12. A mechanism of transition from ventricular fibrillation to tachycardia : effect of calcium channel blockade on the dynamics of rotating waves.
Samie FH; Mandapati R; Gray RA; Watanabe Y; Zuur C; Beaumont J; Jalife J
Circ Res; 2000 Mar; 86(6):684-91. PubMed ID: 10747005
[TBL] [Abstract][Full Text] [Related]
13. Dispersion of 'refractoriness' in noninfarcted myocardium of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarction.
Misier AR; Opthof T; van Hemel NM; Vermeulen JT; de Bakker JM; Defauw JJ; van Capelle FJ; Janse MJ
Circulation; 1995 May; 91(10):2566-72. PubMed ID: 7743618
[TBL] [Abstract][Full Text] [Related]
14. Ventricular fibrillation threshold and local dispersion of refractoriness in isolated rabbit hearts with left ventricular dysfunction.
Burton FL; McPhaden AR; Cobbe SM
Basic Res Cardiol; 2000 Oct; 95(5):359-67. PubMed ID: 11099162
[TBL] [Abstract][Full Text] [Related]
15. Dispersion of refractoriness in canine ventricular myocardium. Effects of sympathetic stimulation.
Opthof T; Misier AR; Coronel R; Vermeulen JT; Verberne HJ; Frank RG; Moulijn AC; van Capelle FJ; Janse MJ
Circ Res; 1991 May; 68(5):1204-15. PubMed ID: 2018987
[TBL] [Abstract][Full Text] [Related]
16. New insights into the beneficial electrophysiologic profile of ranolazine in heart failure: prevention of ventricular fibrillation with increased postrepolarization refractoriness and without drug-induced proarrhythmia.
Frommeyer G; Rajamani S; Grundmann F; Stypmann J; Osada N; Breithardt G; Belardinelli L; Eckardt L; Milberg P
J Card Fail; 2012 Dec; 18(12):939-49. PubMed ID: 23207083
[TBL] [Abstract][Full Text] [Related]
17. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
18. Arrhythmia inducibility and ventricular vulnerability in a chronic feline infarction model.
Wetstein L; Mark R; Kelliher GJ; Friehling T; O'Connor KM; Kowey PR
Am Heart J; 1985 Nov; 110(5):955-60. PubMed ID: 4061270
[TBL] [Abstract][Full Text] [Related]
19. Dose-related shortening of ventricular tachycardia cycle length after administration of the KATP channel opener bimakalim in a 4-day-old chronic infarct anesthetized pig model.
Aidonidis I; Poyatzi A; Stamatiou G; Lymberi M; Stamatoyannis N; Molyvdas PA
J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):222-30. PubMed ID: 19587223
[TBL] [Abstract][Full Text] [Related]
20. Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.
Bui-Xuan B; Aupetit JF; Freysz M; Loufoua-Moundanga J; Faucon G; Timour Q
Arch Int Pharmacodyn Ther; 1996; 331(3):246-62. PubMed ID: 9124997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
